
Clinical-stage biopharmaceutical company AC Immune announced that the US Food and Drug Administration (FDA) has granted its Alzheimer’s disease (AD) …

What originally set you off on your career path? Was the plan always to go into the pharma and biotech …

Roche has announced that it is to terminate two Phase 3 studies investigating the efficacy of its anti-beta-amyloid molecule crenezumab …
AC Immune, a privately-held biotech based in Switzerland, has launched the world’s first trial of a vaccine against a protein …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

